JOINN adheres to the purpose of "Serve for Drug Innovation,
Focus on Safety Assessments and Monitoring of Drugs Throughout Life Cycles"

REVISION FOR ANNUAL CAP FOR CONTINUING CONNECTED TRANSACTION PURSUANT TO BIOAI SERVICE FRAMEWORK AGREEMENT FOR THE YEAR ENDING 31 DECEMBER 2025

REVISION FOR ANNUAL CAP FOR CONTINUING CONNECTED TRANSACTION PURSUANT TO BIOAI SERVICE FRAMEWORK AGREEMENT FOR THE YEAR ENDING 31 DECEMBER 2025

JOINN (1) PROPOSED CHANGE OF THE REGISTERED CAPITAL OF THE COMPANY; AND (2) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION

JOINN (1) PROPOSED CHANGE OF THE REGISTERED CAPITAL OF THE COMPANY; AND (2) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION

JOINN Final dividend in cash for the year ended December 31, 2024

JOINN Final dividend in cash for the year ended December 31, 2024

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 28 FEBRUARY 2025

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 28 FEBRUARY 2025

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2025

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2025

JOINN PROFIT WARNING ANNOUNCEMENT ON THE ESTIMATED DECREASE IN ANNUAL RESULTS FOR THE YEAR OF 2024

JOINN PROFIT WARNING ANNOUNCEMENT ON THE ESTIMATED DECREASE IN ANNUAL RESULTS FOR THE YEAR OF 2024

JOINN LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

JOINN LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

Leave us a message

Thank you for your attention to JOINN. Please fill in the information below, and we will contact you promptly.

Message

Message

top